A link between premenopausal iron deficiency and breast cancer malignancy
暂无分享,去创建一个
Baljit Singh | Qing Yang | L. Chiriboga | Y. Shao | D. Axelrod | Jinqing Li | J. Jian | Xi Huang | J. Smith | Stephanie A. Krauter | Zhao-xu Yang
[1] Baljit Singh,et al. A link between premenopausal iron deficiency and breast cancer malignancy , 2013, BMC Cancer.
[2] F. Torti,et al. Iron and cancer: more ore to be mined , 2013, Nature Reviews Cancer.
[3] S. Narod. Breast cancer in young women , 2012, Nature Reviews Clinical Oncology.
[4] S. Abramson,et al. 17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. , 2012, Endocrinology.
[5] Jisen Dai,et al. Corrigendum to “Effects of iron deficiency and iron overload on angiogenesis and oxidative stress—a potential dual role for iron in breast cancer” [Free Radic. Biol. Med. 50 (2011) 841–847] , 2011 .
[6] Qing Yang,et al. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. , 2011, Free radical biology & medicine.
[7] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[8] Jing Wu,et al. Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis. Iron deficiency and angiogenesis , 2010, Cancer Cell International.
[9] E. Perez,et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. , 2010, The New England journal of medicine.
[10] Robert A. Weinberg,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[11] Heinz Ludwig,et al. Anemia management in oncology and hematology. , 2009, The oncologist.
[12] E. Desantis,et al. Use of erythropoietin-stimulating agents in breast cancer patients: a risk review. , 2009, American Journal of Health-System Pharmacy.
[13] A. Bleyer,et al. Breast cancer before age 40 years. , 2009, Seminars in oncology.
[14] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[15] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[16] Xi Huang. Does iron have a role in breast cancer? , 2008, The Lancet. Oncology.
[17] George Poste,et al. The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.
[18] J. Marks,et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] U. Lendahl,et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.
[20] Richard F Hurrell,et al. Nutritional iron deficiency , 2007, The Lancet.
[21] Ofra Barnett-Griness,et al. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. , 2007, The New England journal of medicine.
[22] G. Rodgers,et al. Intravenous iron [25] , 2007 .
[23] Michael J Thun,et al. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women , 2007, Breast Cancer Research.
[24] M. Hellinger,et al. Reoperation for recurrent colorectal cancer. , 2006, Clinics in colon and rectal surgery.
[25] J. Thiery,et al. Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.
[26] E. Jensen. The contribution of "alternative approaches" to understanding steroid hormone action. , 2005, Molecular Endocrinology.
[27] J. Collins,et al. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[28] Michael Höckel,et al. Hypoxia in breast cancer: role of blood flow, oxygen diffusion distances, and anemia in the development of oxygen depletion. , 2005, Advances in experimental medicine and biology.
[29] Le Zhu,et al. Iron absorption from NaFeEDTA is downregulated in iron-loaded rats. , 2004, The Journal of nutrition.
[30] P. Toniolo,et al. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women. , 2003, Cancer detection and prevention.
[31] J. Caro,et al. Anemia as an independent prognostic factor for survival in patients with cancer , 2001 .
[32] Leila Mohammadi,et al. BMC Cancer , 2001 .
[33] L. Brinton. Hormone replacement therapy and risk for breast cancer. , 1997, Endocrinology and metabolism clinics of North America.
[34] H. Honoré,et al. Breast cancer in young women. , 1979, British medical journal.
[35] J. Nissim. Intravenous Iron , 1954, Nutrition reviews.
[36] Agnes W. O'Brien. Seed and Soil , 1905, The Elementary School Teacher.